Immunoexpression of placental growth factor (PlGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) in the placental bed of preeclamptic women of African ancestry living with HIV infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Immunoexpression of placental growth factor (PlGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) in the placental bed of preeclamptic women of African ancestry living with HIV infection ; volume:163 ; number:1 ; day:23 ; month:11 ; year:2024 ; pages:1-11 ; date:12.2025
Histochemistry and cell biology ; 163, Heft 1 (23.11.2024), 1-11, 12.2025
- Urheber
-
Mlambo, Zinhle P.
Sebitloane, Motshedisi
Naicker, Thajasvarie
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00418-024-02341-6
- URN
-
urn:nbn:de:101:1-2502092104543.510539138642
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Mlambo, Zinhle P.
- Sebitloane, Motshedisi
- Naicker, Thajasvarie
- SpringerLink (Online service)
Ähnliche Objekte (12)
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
Die Wertigkeit von placental growth factor (PlGF) und soluble fms-like tyrosine kinase-1 (sFlt-1) im Rahmen des Erst-Trimester-Screenings.
Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio : A Narrative Review
Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria
The angiogenic factors placental growth factor (PIGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) can be used for predicting preeclampsia and intrauterine growth restriction as well as classifying preeclampsia according to severity : = Die Angiogenesefaktoren Placental growth factor (PIGF) und soluble FMS-like tyrosine Kinase 1 (sFlt-1) könnten sowohl zur Prädiktion der Präeklampsie und der intrauterinen Wachstumsrestriktion, als auch für die Klassifikation des Schweregrades verwendet werden
Diagnosis of placental malaria in poorly fixed and processed placental tissue
Placental mitochondrial function as a driver of angiogenesis and placental dysfunction
Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study
Placental volume
Placental transfer of parathyroid hormone
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
Die Wertigkeit von placental growth factor (PlGF) und soluble fms-like tyrosine kinase-1 (sFlt-1) im Rahmen des Erst-Trimester-Screenings.
Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio : A Narrative Review
Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria
The angiogenic factors placental growth factor (PIGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) can be used for predicting preeclampsia and intrauterine growth restriction as well as classifying preeclampsia according to severity : = Die Angiogenesefaktoren Placental growth factor (PIGF) und soluble FMS-like tyrosine Kinase 1 (sFlt-1) könnten sowohl zur Prädiktion der Präeklampsie und der intrauterinen Wachstumsrestriktion, als auch für die Klassifikation des Schweregrades verwendet werden
Diagnosis of placental malaria in poorly fixed and processed placental tissue
Placental mitochondrial function as a driver of angiogenesis and placental dysfunction
Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study
Placental volume
Placental transfer of parathyroid hormone
Unfractionated heparin displaces sFlt-1 from the placental extracellular matrix
Die Wertigkeit von placental growth factor (PlGF) und soluble fms-like tyrosine kinase-1 (sFlt-1) im Rahmen des Erst-Trimester-Screenings.
Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio : A Narrative Review
Prediction of Adverse Pregnancy Outcome Related to Placental Dysfunction Using the sFlt-1/PlGF Ratio: A Narrative Review
The prognostic utility of soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PIGF) biomarkers for predicting preeclampsia: a secondary analysis of data from the INSPIRE trial
Prenatal Clinical Assessment of sFlt-1 (Soluble fms-like Tyrosine Kinase-1)/PlGF (Placental Growth Factor) Ratio as a Diagnostic Tool for Preeclampsia, Pregnancy-induced Hypertension, and Proteinuria
The angiogenic factors placental growth factor (PIGF) and soluble FMS-like tyrosine kinase 1 (sFlt-1) can be used for predicting preeclampsia and intrauterine growth restriction as well as classifying preeclampsia according to severity : = Die Angiogenesefaktoren Placental growth factor (PIGF) und soluble FMS-like tyrosine Kinase 1 (sFlt-1) könnten sowohl zur Prädiktion der Präeklampsie und der intrauterinen Wachstumsrestriktion, als auch für die Klassifikation des Schweregrades verwendet werden
Diagnosis of placental malaria in poorly fixed and processed placental tissue
Placental mitochondrial function as a driver of angiogenesis and placental dysfunction
Periodic assessment of plasma sFlt-1 and PlGF concentrations and its association with placental morphometry in gestational hypertension (GH) - a prospective follow-up study
Placental volume